CIS Insulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Rapid Acting, Long Acting, Premixed, Premixed Analog, Short Acting, and Intermediate Acting); Source (Human Recombinant, and Analogs); Application (Type II Diabetes, and Type I Diabetes), and Geography

Report Code: TIPRE00022704 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Insulin is one of the essential peptide hormones produced by beta cells in the pancreas. It maintains the metabolism of carbohydrates and fats by promoting glucose absorption from the blood to skeletal muscles and fat tissue and by causing fat to be stored rather than used for energy. Insufficient production of insulin results to accumulation of sugar in blood cells which causes diabetes.

MARKET SCOPE

The "Global CIS Insulin Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of the CIS insulin market with detailed market segmentation by product, source, application, and geography. The report provides key statistics on the market status of the leading CIS insulin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on product, the global CIS insulin market is segmented into rapid acting, long acting, premixed, premixed analog, short acting, intermediate acting.
  •  On the basis of source, the market is segmented into human recombinant, analogs
  •  On the basis of application, the market is segmented into type ii diabetes, type i diabetes.

MARKET DYNAMICS
Drivers

  •   Rise in the incidences of diabetes cases worldwide.
  •   Rise in the several health disorders due to changing lifestyle.

Restraints

  •   The strict regulatory requirements for approval of insulin and high cost of insulin are the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The CIS insulin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the CIS insulin market in these regions.

IMPACT OF COVID-19 ON CIS INSULIN MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the CIS insulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from CIS insulin market are anticipated to lucrative growth opportunities in the future with the rising demand for CIS insulin in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the CIS insulin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Bristol-Myers Squibb Company,
  •  Boehringer Ingelheim
  •  Eli Lilly and Company
  •  Novo Nordisk
  •  Sanofi
  •  Novartis AG
  •  Pfizer, Inc
  •  Merck
  •  Takeda Pharmaceuticals
  •  Oramed Pharmaceuticals

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 CIS Insulin Market - By Product
1.3.2 CIS Insulin Market - By Source
1.3.3 CIS Insulin Market - By Application
1.3.4 CIS Insulin Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CIS INSULIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CIS INSULIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CIS INSULIN MARKET - GLOBAL MARKET ANALYSIS
6.1. CIS INSULIN - GLOBAL MARKET OVERVIEW
6.2. CIS INSULIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CIS INSULIN MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. RAPID ACTING
7.3.1. Overview
7.3.2. Rapid Acting Market Forecast and Analysis
7.4. LONG ACTING
7.4.1. Overview
7.4.2. Long Acting Market Forecast and Analysis
7.5. PREMIXED
7.5.1. Overview
7.5.2. Premixed Market Forecast and Analysis
7.6. PREMIXED ANALOG
7.6.1. Overview
7.6.2. Premixed Analog Market Forecast and Analysis
7.7. SHORT ACTING
7.7.1. Overview
7.7.2. Short Acting Market Forecast and Analysis
7.8. INTERMEDIATE ACTING
7.8.1. Overview
7.8.2. Intermediate Acting Market Forecast and Analysis
8. CIS INSULIN MARKET - REVENUE AND FORECASTS TO 2028 - SOURCE
8.1. OVERVIEW
8.2. SOURCE MARKET FORECASTS AND ANALYSIS
8.3. HUMAN RECOMBINANT
8.3.1. Overview
8.3.2. Human Recombinant Market Forecast and Analysis
8.4. ANALOGS
8.4.1. Overview
8.4.2. Analogs Market Forecast and Analysis
9. CIS INSULIN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. TYPE II DIABETES
9.3.1. Overview
9.3.2. Type II Diabetes Market Forecast and Analysis
9.4. TYPE I DIABETES
9.4.1. Overview
9.4.2. Type I Diabetes Market Forecast and Analysis
10. CIS INSULIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America CIS Insulin Market Overview
10.1.2 North America CIS Insulin Market Forecasts and Analysis
10.1.3 North America CIS Insulin Market Forecasts and Analysis - By Product
10.1.4 North America CIS Insulin Market Forecasts and Analysis - By Source
10.1.5 North America CIS Insulin Market Forecasts and Analysis - By Application
10.1.6 North America CIS Insulin Market Forecasts and Analysis - By Countries
10.1.6.1 United States CIS Insulin Market
10.1.6.1.1 United States CIS Insulin Market by Product
10.1.6.1.2 United States CIS Insulin Market by Source
10.1.6.1.3 United States CIS Insulin Market by Application
10.1.6.2 Canada CIS Insulin Market
10.1.6.2.1 Canada CIS Insulin Market by Product
10.1.6.2.2 Canada CIS Insulin Market by Source
10.1.6.2.3 Canada CIS Insulin Market by Application
10.1.6.3 Mexico CIS Insulin Market
10.1.6.3.1 Mexico CIS Insulin Market by Product
10.1.6.3.2 Mexico CIS Insulin Market by Source
10.1.6.3.3 Mexico CIS Insulin Market by Application
10.2. EUROPE
10.2.1 Europe CIS Insulin Market Overview
10.2.2 Europe CIS Insulin Market Forecasts and Analysis
10.2.3 Europe CIS Insulin Market Forecasts and Analysis - By Product
10.2.4 Europe CIS Insulin Market Forecasts and Analysis - By Source
10.2.5 Europe CIS Insulin Market Forecasts and Analysis - By Application
10.2.6 Europe CIS Insulin Market Forecasts and Analysis - By Countries
10.2.6.1 Germany CIS Insulin Market
10.2.6.1.1 Germany CIS Insulin Market by Product
10.2.6.1.2 Germany CIS Insulin Market by Source
10.2.6.1.3 Germany CIS Insulin Market by Application
10.2.6.2 France CIS Insulin Market
10.2.6.2.1 France CIS Insulin Market by Product
10.2.6.2.2 France CIS Insulin Market by Source
10.2.6.2.3 France CIS Insulin Market by Application
10.2.6.3 Italy CIS Insulin Market
10.2.6.3.1 Italy CIS Insulin Market by Product
10.2.6.3.2 Italy CIS Insulin Market by Source
10.2.6.3.3 Italy CIS Insulin Market by Application
10.2.6.4 Spain CIS Insulin Market
10.2.6.4.1 Spain CIS Insulin Market by Product
10.2.6.4.2 Spain CIS Insulin Market by Source
10.2.6.4.3 Spain CIS Insulin Market by Application
10.2.6.5 United Kingdom CIS Insulin Market
10.2.6.5.1 United Kingdom CIS Insulin Market by Product
10.2.6.5.2 United Kingdom CIS Insulin Market by Source
10.2.6.5.3 United Kingdom CIS Insulin Market by Application
10.2.6.6 Rest of Europe CIS Insulin Market
10.2.6.6.1 Rest of Europe CIS Insulin Market by Product
10.2.6.6.2 Rest of Europe CIS Insulin Market by Source
10.2.6.6.3 Rest of Europe CIS Insulin Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific CIS Insulin Market Overview
10.3.2 Asia-Pacific CIS Insulin Market Forecasts and Analysis
10.3.3 Asia-Pacific CIS Insulin Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific CIS Insulin Market Forecasts and Analysis - By Source
10.3.5 Asia-Pacific CIS Insulin Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific CIS Insulin Market Forecasts and Analysis - By Countries
10.3.6.1 Australia CIS Insulin Market
10.3.6.1.1 Australia CIS Insulin Market by Product
10.3.6.1.2 Australia CIS Insulin Market by Source
10.3.6.1.3 Australia CIS Insulin Market by Application
10.3.6.2 China CIS Insulin Market
10.3.6.2.1 China CIS Insulin Market by Product
10.3.6.2.2 China CIS Insulin Market by Source
10.3.6.2.3 China CIS Insulin Market by Application
10.3.6.3 India CIS Insulin Market
10.3.6.3.1 India CIS Insulin Market by Product
10.3.6.3.2 India CIS Insulin Market by Source
10.3.6.3.3 India CIS Insulin Market by Application
10.3.6.4 Japan CIS Insulin Market
10.3.6.4.1 Japan CIS Insulin Market by Product
10.3.6.4.2 Japan CIS Insulin Market by Source
10.3.6.4.3 Japan CIS Insulin Market by Application
10.3.6.5 South Korea CIS Insulin Market
10.3.6.5.1 South Korea CIS Insulin Market by Product
10.3.6.5.2 South Korea CIS Insulin Market by Source
10.3.6.5.3 South Korea CIS Insulin Market by Application
10.3.6.6 Rest of Asia-Pacific CIS Insulin Market
10.3.6.6.1 Rest of Asia-Pacific CIS Insulin Market by Product
10.3.6.6.2 Rest of Asia-Pacific CIS Insulin Market by Source
10.3.6.6.3 Rest of Asia-Pacific CIS Insulin Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa CIS Insulin Market Overview
10.4.2 Middle East and Africa CIS Insulin Market Forecasts and Analysis
10.4.3 Middle East and Africa CIS Insulin Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa CIS Insulin Market Forecasts and Analysis - By Source
10.4.5 Middle East and Africa CIS Insulin Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa CIS Insulin Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa CIS Insulin Market
10.4.6.1.1 South Africa CIS Insulin Market by Product
10.4.6.1.2 South Africa CIS Insulin Market by Source
10.4.6.1.3 South Africa CIS Insulin Market by Application
10.4.6.2 Saudi Arabia CIS Insulin Market
10.4.6.2.1 Saudi Arabia CIS Insulin Market by Product
10.4.6.2.2 Saudi Arabia CIS Insulin Market by Source
10.4.6.2.3 Saudi Arabia CIS Insulin Market by Application
10.4.6.3 U.A.E CIS Insulin Market
10.4.6.3.1 U.A.E CIS Insulin Market by Product
10.4.6.3.2 U.A.E CIS Insulin Market by Source
10.4.6.3.3 U.A.E CIS Insulin Market by Application
10.4.6.4 Rest of Middle East and Africa CIS Insulin Market
10.4.6.4.1 Rest of Middle East and Africa CIS Insulin Market by Product
10.4.6.4.2 Rest of Middle East and Africa CIS Insulin Market by Source
10.4.6.4.3 Rest of Middle East and Africa CIS Insulin Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America CIS Insulin Market Overview
10.5.2 South and Central America CIS Insulin Market Forecasts and Analysis
10.5.3 South and Central America CIS Insulin Market Forecasts and Analysis - By Product
10.5.4 South and Central America CIS Insulin Market Forecasts and Analysis - By Source
10.5.5 South and Central America CIS Insulin Market Forecasts and Analysis - By Application
10.5.6 South and Central America CIS Insulin Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil CIS Insulin Market
10.5.6.1.1 Brazil CIS Insulin Market by Product
10.5.6.1.2 Brazil CIS Insulin Market by Source
10.5.6.1.3 Brazil CIS Insulin Market by Application
10.5.6.2 Argentina CIS Insulin Market
10.5.6.2.1 Argentina CIS Insulin Market by Product
10.5.6.2.2 Argentina CIS Insulin Market by Source
10.5.6.2.3 Argentina CIS Insulin Market by Application
10.5.6.3 Rest of South and Central America CIS Insulin Market
10.5.6.3.1 Rest of South and Central America CIS Insulin Market by Product
10.5.6.3.2 Rest of South and Central America CIS Insulin Market by Source
10.5.6.3.3 Rest of South and Central America CIS Insulin Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CIS INSULIN MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. CIS INSULIN MARKET, KEY COMPANY PROFILES
13.1. BRISTOL-MYERS SQUIBB COMPANY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BOEHRINGER INGELHEIM
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ELI LILLY AND COMPANY
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NOVO NORDISK
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SANOFI
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NOVARTIS AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PFIZER, INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MERCK
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. TAKEDA PHARMACEUTICALS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ORAMED PHARMACEUTICALS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Bristol-Myers Squibb Company,
2. Boehringer Ingelheim
3. Eli Lilly and Company
4. Novo Nordisk
5. Sanofi
6. Novartis AG
7. Pfizer, Inc
8. Merck
9. Takeda Pharmaceuticals
10. Oramed Pharmaceuticals
TIPRE00022704
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking